LivaNova Investor Relations Material
Latest events
Q2 2025
LivaNova
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from LivaNova PLC
Access all reports
LivaNova PLC is a global medical technology company that develops and manufactures devices for use in cardiovascular and neuromodulation therapies. The company’s products are designed to address critical conditions such as heart failure, obstructive sleep apnea, and epilepsy. LivaNova’s cardiovascular segment focuses on cardiac surgery and advanced circulatory support, while its neuromodulation segment offers devices for treating neurological disorders. The company is headquartered in London, England, and its shares are listed on the NASDAQ.
Key slides for LivaNova PLC
Q2 2025
LivaNova PLC
Q1 2025
LivaNova PLC
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
LIVN
Country
🇺🇸 United States